CIR
This article was originally published in The Rose Sheet
Executive Summary
Polyacrylamide safety data to be supplied by chemical manufacturer SNF Floerger by October for review at the panel's December meeting. The Cosmetic Ingredient Review expert panel issued a safe as used determination on the ingredient in 1990 when formulated with less than .1% acrylamide monomer content. Since the decision, CIR received risk assessment data from the European Union's Scientific Committee on Cosmetic Products and Non-Food Products suggesting acrylamide "may represent an unacceptable high risk of cancer." The panel discussed polyacrylamide at a meeting in Bethesda, Md. May 18-19